|
by: Geoffrey M. Cooper
publisher: Jones & Bartlett Learning, published: 1995-01-15
ASIN: 0867209372
EAN: 9780867209372
sales rank: 1524916
The Second Edition Of This Authoritative Text Details Major Advances And Developments In The Field, Such As The Identification Of Many New Tumor Suppressor Genes And The Striking Progress In Understanding Signal Transduction Pathways Leading To Cell Proliferation. Oncogenes, Second Edition, Addresses The Needs Of Advanced Undergraduates, Graduate Students, Medical Students, Physicians, And Scientists By Examining The Current State Of Oncogene Study And Where Future Research May Lead.
|
|
by: Henry R. Bourne
publisher: University of California Press, published: 2011-11-01
ASIN: 0983463921
EAN: 9780983463924
sales rank: 558991
|
|
by: Icon Group International
publisher: ICON Group International, Inc., published: 2010-03-10
ASIN: 1114430668
EAN: 9781114430662
sales rank: 6882353
Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Oncogene," including when used in literature (e.g. all authors that might have Oncogene in their name). As such, this book represents the largest compilation of timeline events associated with Oncogene when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts, social sciences (linguistics, history, geography, economics, sociology, political science), business, computer science, literature, law, medicine, psychology, mathematics, chemistry, physics, biology and other physical sciences. This "data dump" results in a comprehensive set of entries for a bibliographic and/or event-based timeline on the proper name Oncogene, since editorial decisions to include or exclude events is purely a linguistic process. The resulting entries are used under license or with permission, used under "fair use" conditions, used in agreement with the original authors, or are in the public domain.
|
|
by: Dennis W. Ross
publisher: Springer, published: 1998-08-21
ASIN: 0387983929
EAN: 9780387983929
sales rank: 1896189
Providing the physician with a solid understanding of molecular biology and its applications for the diagnosis and treatment of cancer, this book reviews the basic molecular and other principles of cancer medicine, including controls of cell growth and senescence, carcinogenesis, tumorogenesis, and epidemiology. The second part of the book gives clinical examples to demonstrate the basic science principles, including chapters on leukaemia, colon cancer, and breast cancer. A chapter on molecular diagnostics and screening plus a chapter on new molecular anti-cancer therapies allow readers an insight into current therapies as well as the future of molecular cancer medicine. A useful glossary defines new terminology at-a-glance. Written in a user-friendly, conversational format, this text will be welcomed by all physicians eager to sharpen their own understanding of molecular cancer medicine as well as to help them provide patients with balanced information on the advances and limitations of current treatment options.
|
|
by: Harvey Bialy
publisher: North Atlantic Books, published: 2004-08-01
ASIN: 1556435312
EAN: 9781556435317
sales rank: 1494816
According to author Harvey Bialy, the work of molecular biologist Peter Duesberg has been grossly distorted by the media and scientific establishments. Until recently, the scientific community—and most notably, those from the National Institute for Health—have been unwilling to look at his provocative theories of different causes for cancer and HIV/AIDS. Inspired by UC Berkeley's rare creation of an archive for Duesberg's papers, this book explores Duesberg's early groundbreaking work with viruses and oncogenes, his contentious fights with other scientists, and the profound influence of his life's work.
|
|
|
publisher: Cold Spring Harbor Laboratory Pr, published: 1990-03
ASIN: 0879693363
EAN: 9780879693367
sales rank: 1428135
|
|
|
by: Owen Witte
publisher: Cold Spring Harbor Laboratory Press, published: 1992-10-01
ASIN: 0879694068
EAN: 9780879694067
sales rank: 2532496
Ten articles cover a broad range of concepts to be considered in the study of leukemia, such as the mechanisms regulating the hierarchy of primitive hematopoietic cells, avian erythroblastosis as a model to study oncogene cooperation in leukemia, and an antidote to programmed cell death.
|
|
publisher: Springer, published: 2010-11-25
ASIN: 3642098401
EAN: 9783642098406
sales rank: 4919629
In 1920s, Otto Warburg described the phenomenon of ‘aerobic glycolysis’, the ability of tumour cells to convert glucose to lactate in the presence of normal oxygen conditions. Warburg’s hypothesis of an altered metabolism in cancer cells found no immediate acceptance, though it was latter confirmed for most human tumours. With the advent of molecular biology the focus in tumour research has shifted towards the search for oncogenes. However, the interest in cancer molecular profiling eventually led to a renaissance of the Warburg effect trying to combine genetic alterations with effects on metabolism with the help of modern analytic technologies to rapidly analyze broad varieties of metabolites in various tissues and bodyfluids (metabonomics).
|
|
publisher: Birkhäuser Basel, published: 1997-07-15
ASIN: 3764354860
EAN: 9783764354862
sales rank: 5907522
|
|
by: Robin Hesketh
publisher: Academic Press, published: 1997-08-06
ASIN: 0123445485
EAN: 9780123445483
sales rank: 4975676
The Second Edition of The Oncogene and Tumour Suppressor Gene FactsBook has been completely revised, updated, and expanded by 60%. The book contains more than 80 entries on oncogenes including JUN, MYC, and RAS, as well as DNA tumour viruses, tumour suppressor genes, including p53, retinoblastoma, BRCA1, BRCA2, VHL, F2FL, and essential material on angiogenesis and metastasis, apoptosis, cell cycle control, and gene therapy.
Key Features * Includes much new data on this fast-moving field, including newly discovered oncogenes * Summarizes the clinical association and molecular properties of all known oncogenes and tumor suppression genes * Contains more than 2000 terms for reference and further research * Revised to included signaling pathways, apoptosis, and metastasis
|